CEO's On the Move

Sirtex Medical Limited Appoints Andrew McLean as Chief Executive Officer, Effective June 5, 2017
05/24/2017
Sirtex Medical Limited (SRX:AU:Australian Stock Exchange - SEATS) Sirtex Medical Limited announced the appointment of Mr. Andrew McLean as Chief Executive Officer, effective June 5, 2017. Andrew has over 20 years of experience with a track record of success in regional and global leadership roles. In taking up leadership of Sirtex, Andrew will return to Sydney from ...

Upcoming Board Meetings

Timex Group India Limited
(TIMX:IN:Bombay Stock Exchange)
May 25, 2017
Timex Group India Limited, Board Meeting, May 25, 2017. Agenda: To consider audited financial results of the company for the quarter and year ending on March 31, 2017.
Announced 03/31/17
Timex Group India Limited Key Board Members
Sharmila Sahai
Managing Director and Additional Director
Gagan Singh
Non-Executive & Independent Director

Executive Changes

Green Cross Health Limited Announces Executive Changes; Declares Final Dividend, Payable on June 23, 2017
05/24/17
Green Cross Health Limited announced Mr. Peter Williams was added to the Board as an alternate for Mr. Patrick Davies. He will formally replace Patrick as a Non-Executive Director from May 2017. Peter is an executive of The Zuellig Group which has significant healthcare interests in Asia Pacific. He is a Director of a number of companies including, in New Zealand, Ebos Group Ltd. and CB Norwood Distributors Ltd. At the conclusion of Annual General Meeting Mr. Keith Rushbrook will step down from his position of Independent Director after eight years on the Board. The company declares fully imputed final dividend of 3.5 cents per share to shareholders on the register on 9 June 2017. The dividend will be paid on 23 June 2017.
Lewis Group Limited Announces Management Changes
05/24/17
Lewis Group Limited announced that Independent non-executive chairman David Nurek has advised the board that he plans to retire after serving as a director and chairman since the group's listing on the JSE in 2004. The board has nominated independent non-executive director Hilton Saven to succeed Mr. Nurek. Through a managed succession process, Mr. Nurek has agreed to stand for re-election as a director at the forthcoming annual general meeting in August 2017. He will serve as a director until a suitable candidate has been appointed to the board to succeed Mr. Saven as chairman of the audit committee, at which time he will formally retire from the board and be succeeded by Mr. Saven. Daphne Motsepe and Adheera Bodasing have been appointed as non-executive directors with effect from 1 June 2017. Ms. Motsepe is an experienced banking executive and company director. She was formerly chief executive of unsecured lending at Absa and also served as managing director of Postbank. She is currently a non-executive director of Edcon, Mercantile Bank Holdings, Rand Mutual Assurance Company and Kapela Investment Holdings. The company also announced that Independent non-executive director Ben van der Ross will be retiring from the board at the forthcoming AGM. Mr. van der Ross has been a director since 2004 and also serves as chairman of the group's remuneration committee.
Lewis Group Limited Announces Executive Changes
05/24/17
Lewis Group announced the appointment of Jacques Bestbier as chief financial officer ("CFO") designate with effect from 1 June 2017. Jacques has been general manager: administration for most of his career with the group since joining in 2012. He is an experienced chartered accountant with a background in the short-term insurance, banking and retail sectors. Prior to joining Lewis he spent six years with the Shoprite Group in financial and divisional management roles. He will succeed Les Davies, who has served as the group's CFO and financial director since 1989. Les will be stepping down as CFO and as an executive director of Lewis Group with effect from 31 March 2018.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Top Compensated Executives at SRX:AU

Name/TitleAnnual Compensation
Nigel LangeA$716.3K
Acting Chief Executive Officer
Darren SmithA$586.6K
Chief Financial Officer and Company Secretary
David CadeA$567.4K
Chief Medical Officer
Robert HardieA$543.9K
Global Head of Operations
Compensation as of Fiscal Year 2016. All Compensation is in USD.

Average Compensation in the Biotechnology Industry

Biotechnology
$492.1K
Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.